long-residence time EZH2 inhibitor

oral efficacy in xenograft model

from optimatization of prior EZH2 inhibitor

"ACS Med. Chem. Lett., Mar. 26, 2020

Constellation Pharma., Cambridge, MA

Constellation EZH2 inhibitor

Constellation EZH2 inhibitor (Constellation oral in vivo long-residence time EZH2 inhibitor)


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: